BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 35852664)

  • 41. Membrane Type 1 Matrix Metalloproteinase induces an epithelial to mesenchymal transition and cancer stem cell-like properties in SCC9 cells.
    Yang CC; Zhu LF; Xu XH; Ning TY; Ye JH; Liu LK
    BMC Cancer; 2013 Apr; 13():171. PubMed ID: 23548172
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Chronic restraint stress promotes the tumorigenic potential of oral squamous cell carcinoma cells by reprogramming fatty acid metabolism via CXCL3 mediated Wnt/β-catenin pathway.
    Lou F; Long H; Luo S; Liu Y; Pu J; Wang H; Ji P; Jin X
    Exp Neurol; 2023 Jan; 359():114268. PubMed ID: 36343679
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Incomplete epithelial-mesenchymal transition in p16-positive squamous cell carcinoma cells correlates with β-catenin expression.
    Umbreit C; Flanjak J; Weiss C; Erben P; Aderhold C; Faber A; Stern-Straeter J; Hoermann K; Schultz JD
    Anticancer Res; 2014 Dec; 34(12):7061-9. PubMed ID: 25503133
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Wnt/β-catenin signaling pathway participates in the effect of miR-626 on oral squamous cell carcinoma by targeting RASSF4.
    Cui SH; Hu XD; Yan Y
    J Oral Pathol Med; 2021 Nov; 50(10):1005-1017. PubMed ID: 34121238
    [TBL] [Abstract][Full Text] [Related]  

  • 45. MiR-92a inhibits proliferation and promotes apoptosis of OSCC cells through Wnt/β-catenin signaling pathway.
    Zheng TL; Cen K
    Eur Rev Med Pharmacol Sci; 2020 May; 24(9):4803-4809. PubMed ID: 32432743
    [TBL] [Abstract][Full Text] [Related]  

  • 46. ENO1 Promotes OSCC Migration and Invasion by Orchestrating IL-6 Secretion from Macrophages via a Positive Feedback Loop.
    Lin Y; Zhang W; Liu L; Li W; Li Y; Li B
    Int J Mol Sci; 2023 Jan; 24(1):. PubMed ID: 36614179
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Knockdown of lncRNA IGF2BP2-AS1 inhibits proliferation and migration of oral squamous cell carcinoma cells via the Wnt/β-catenin pathway.
    Tong S; Wang X; Guo X; Lu Z
    J Oral Pathol Med; 2022 Mar; 51(3):272-280. PubMed ID: 34637162
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Dysfunction of Cl
    Kei Kakinouchi ; Yoshie S; Tsuji S; Murono S; Hazama A
    Biochem Biophys Res Commun; 2021 May; 555():95-101. PubMed ID: 33813282
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Identification of E2F transcription factor 7 as a novel potential biomarker for oral squamous cell carcinoma.
    Zhou P; Xiao L; Xu X
    Head Face Med; 2021 Feb; 17(1):7. PubMed ID: 33637098
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [The experimental study of CXC subfamily receptor 4 modulating oral squamous cell carcinoma epithelial-mesenchymal transition to influence lymphatic metastasis in vitro].
    Zhang S; Wang B; Zhou X; Yue K; Wang X
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2014 Mar; 49(3):171-6. PubMed ID: 24820786
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Epithelial-mesenchymal transition (EMT) markers have prognostic impact in multiple primary oral squamous cell carcinoma.
    da Silva SD; Morand GB; Alobaid FA; Hier MP; Mlynarek AM; Alaoui-Jamali MA; Kowalski LP
    Clin Exp Metastasis; 2015 Jan; 32(1):55-63. PubMed ID: 25433796
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Human Primary Epithelial Cells Acquire an Epithelial-Mesenchymal-Transition Phenotype during Long-Term Infection by the Oral Opportunistic Pathogen,
    Lee J; Roberts JS; Atanasova KR; Chowdhury N; Han K; Yilmaz Ö
    Front Cell Infect Microbiol; 2017; 7():493. PubMed ID: 29250491
    [No Abstract]   [Full Text] [Related]  

  • 53. Isoorientin inhibits epithelial-to-mesenchymal properties and cancer stem-cell-like features in oral squamous cell carcinoma by blocking Wnt/β-catenin/STAT3 axis.
    Liu SC; Huang CS; Huang CM; Hsieh MS; Huang MS; Fong IH; Yeh CT; Lin CC
    Toxicol Appl Pharmacol; 2021 Aug; 424():115581. PubMed ID: 34019859
    [TBL] [Abstract][Full Text] [Related]  

  • 54. LncRNA AC007271.3 promotes cell proliferation, invasion, migration and inhibits cell apoptosis of OSCC via the Wnt/β-catenin signaling pathway.
    Shao TR; Zheng ZN; Chen YC; Wu QQ; Huang GZ; Li F; Zeng WS; Lv XZ
    Life Sci; 2019 Dec; 239():117087. PubMed ID: 31759044
    [TBL] [Abstract][Full Text] [Related]  

  • 55. miR-654-5p Targets GRAP to Promote Proliferation, Metastasis, and Chemoresistance of Oral Squamous Cell Carcinoma Through Ras/MAPK Signaling.
    Lu M; Wang C; Chen W; Mao C; Wang J
    DNA Cell Biol; 2018 Apr; 37(4):381-388. PubMed ID: 29364705
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Loss of VHL expression contributes to epithelial-mesenchymal transition in oral squamous cell carcinoma.
    Zhang S; Zhou X; Wang B; Zhang K; Liu S; Yue K; Zhang L; Wang X
    Oral Oncol; 2014 Sep; 50(9):809-17. PubMed ID: 24998140
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Bovine lactoferrin reverses programming of epithelial-to-mesenchymal transition to mesenchymal-to-epithelial transition in oral squamous cell carcinoma.
    Chea C; Miyauchi M; Inubushi T; Okamoto K; Haing S; Nguyen PT; Imanaka H; Takata T
    Biochem Biophys Res Commun; 2018 Dec; 507(1-4):142-147. PubMed ID: 30415774
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Fibulin-4 is associated with prognosis of endometrial cancer patients and inhibits cancer cell invasion and metastasis via Wnt/β-catenin signaling pathway.
    Wang T; Wang M; Fang S; Wang Q; Fang R; Chen J
    Oncotarget; 2017 Mar; 8(12):18991-19012. PubMed ID: 28177909
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Long non-coding RNA CCAT1 is a prognostic biomarker for the progression of oral squamous cell carcinoma via miR-181a-mediated Wnt/β-catenin signaling pathway.
    Li GH; Ma ZH; Wang X
    Cell Cycle; 2019 Nov; 18(21):2902-2913. PubMed ID: 31599709
    [TBL] [Abstract][Full Text] [Related]  

  • 60. MicroRNA-155-5p is associated with oral squamous cell carcinoma metastasis and poor prognosis.
    Baba O; Hasegawa S; Nagai H; Uchida F; Yamatoji M; Kanno NI; Yamagata K; Sakai S; Yanagawa T; Bukawa H
    J Oral Pathol Med; 2016 Apr; 45(4):248-55. PubMed ID: 26307116
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.